Ownership Summary
Recent 13F filings as of September 2025 show that 6 institutional investors hold a position in Molecular Partners Ag (NASDAQ:MOLN).
- These investors collectively held 9.6% of the company's total shares outstanding in September 2025, down from 9.7% in June 2025.
- In percentage terms, this reflects as a holdings change of -0.13% quarter on quarter, and an increase of 20.00% year over year.
- Of these 6 institutional investors, 1 increased their holdings in Molecular Partners Ag, while 1 of them reduced positions, and 4 investors maintained their exposure.
- Collectively, institutional investors decreased their stake in Molecular Partners Ag to 3.58Mn shares as of September 2025, a change that is down by 4.75K shares quarter on quarter and up 2.73Mn shares year over year.
- SUVRETTA CAPITAL MANAGEMENT, LLC's holding of 2.22Mn shares as of September 30, 2025 makes it the primary institutional investor in Molecular Partners Ag, owning 5.94% of the stock.
- Among the most significant buyers of Molecular Partners Ag during September 2025 were EverSource Wealth Advisors, LLC (114).
- Leading sellers of Molecular Partners Ag stock in September 2025 included UBS Group AG (4.86K).
- The top 6 institutional holders of Molecular Partners Ag for the quarter ending September 2025 included SUVRETTA CAPITAL MANAGEMENT, LLC (2.22Mn), BVF INC/IL (1.35Mn), UBS Group AG (5.34K), MORGAN STANLEY (367), BANK OF AMERICA CORP /DE/ (157), EverSource Wealth Advisors, LLC (155).